Product Name :
Anti-TFPI(Befovacimab Biosimilar) Antibody
Applications:
ELISA,Flow Cyt
Reactivity :
Human TFPI
Conjugate:
Unconjugated
Advantages :
High lot-to-lot consistencyIncreased sensitivity and higher affinityAnimal-free production
Description:
| Description: Anti-TFPI(Befovacimab Biosimilar) Antibody is a biosimilar antibody directed against Human TFPI.{{159768-75-9} MedChemExpress|{159768-75-9} Biological Activity|{159768-75-9} In stock|{159768-75-9} manufacturer} | Isotype: Human IgG2 | Conjugate: Unconjugated | Specificity: Human TFPI | Clonality: Monoclonal | Purity: Recombinant Expression and Affinity purified | Concentration: 1mg/ml | Formation: Liquid, 10mM PBS (pH 7.{{1936529-65-5} medchemexpress|{1936529-65-5} Protocol|{1936529-65-5} Formula|{1936529-65-5} custom synthesis} 5) | Storage: Store at –20 °C, (Avoid freeze/thaw cycles)
Description2 :
Anti-TFPI(Befovacimab Biosimilar) Antibody is a biosimilar antibody directed against Human TFPI.
Immunogen:
Host :
Isotype:
Human IgG2
Purity :
Recombinant Expression and Affinity purified
Buffer :
Storage :
Function:
ELISA: 1:5000-1:20000Flow Cyt: 1:200-1:1000Other tested applications.PMID:27809436 Dilution factors are presented in the form of a range because the optimal dilution is a function of many factors, such as antigen density, permeability, etc. The actual dilution used must be determined empirically.